サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：E型肝炎診断検査の世界市場-2022-2029
市場調査レポート
商品コード
1129237

E型肝炎診断検査の世界市場-2022-2029

Global Hepatitis E Diagnostic Tests Market - 2022-2029
出版日: | 発行: DataM Intelligence | ページ情報: 英文 180 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.70円
E型肝炎診断検査の世界市場-2022-2029
出版日: 2022年09月29日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場力学

E型肝炎の新規リコンビナントタンパク質ベースの診断キットの開発が、市場成長の原動力になると予想されます。

Biotech Consortium India Limitedは、他の市販のアッセイキットと比較して、HEV感染を検出するための感度の高い検査技術を開発しました。この技術は、E型肝炎検査キットの開発にあたり、豚のHEVのオープンリーディングフレーム-2を利用したものです。現在の技術では、遺伝子配列が2％変更され、HEVタンパク質の生産量が増加し、患者の血清試料中のタンパク質の同定が容易になり、診断キットの有効性が高まりました。これは、ワクチン作製に利用できる技術プラットフォームです。さらに、この技術は、遺伝子型1および4を検出し、より高い感度を有するという利点があります。したがって、上記の記述から、予測期間中に市場を牽引することが期待されます。

抑制要因

人々の認識不足、診断方法の高コスト、不適切な償還規制などが、予測期間中に市場が阻害される要因の1つです。

E型肝炎診断検査の世界市場- 産業分析

E型肝炎診断検査市場は、ポーターのファイブフォース、償還シナリオ、価格分析、サプライチェーンなど、様々な業界要因に基づく市場の詳細な分析を提供します。

COVID-19の影響分析

COVID-19のパンデミックは、ヘルスケアシステムと市場に中程度の影響を与えています。COVID-19の流行はヘルスケアシステムを混乱させ、基本的な臨床ケア、E型肝炎ウイルス抗体検査、治療の提供をより困難なものにしています。その結果、パンデミック時にE型肝炎ウイルスと診断されていなかった人が、その後、より進行した状態で発見されることにより、罹患率や死亡率が増加する可能性があります。さらに、COVID-19のパンデミック緩和策の一環として、CDCは日常診療の延期と重要でない業務の遅延に関するガイドラインを発表しました。このアドバイスにより、患者は不必要な対面診療を避け、遠隔医療、患者ポータル、電話、電子メールを通じて医療従事者とコミュニケーションをとる必要があります。

さらに、パンデミックはサプライチェーンとプロセスに支障をきたします。多くの企業は、製品の入手可能性を確保し、サプライチェーンを保護するために、他の地域へと変化していくでしょう。したがって、上記の文から、市場は影響を受け、それは経済活動の再開と迅速にトラクションを得ることが期待されるようになっています。

世界のE型肝炎診断検査市場レポートでは、約45+市場データ表、40+図、180ページの構成で提供しています。

目次

第1章 調査手法と調査範囲

  • 調査手法
  • 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場の力学

  • 市場インパクトファクター
    • 促進要因
      • E型肝炎の新規リコンビナントタンパク質ベースの診断キットの開発は、市場成長の原動力になると予想されます。
    • 抑制要因
      • 診断方法のコスト高と償還規制の不備が市場成長の妨げになると予想されます。
    • 市場参入の機会
    • 影響分析

第5章 産業分析

  • サプライチェーン分析
  • 価格設定分析
  • アンメットニーズ分析

第6章 COVID-19の分析

  • COVID-19の市場分析
    • COVID-19以前の市場シナリオ
    • COVID-19の現在の市場シナリオ
    • COVID-19の後、あるいは将来のシナリオ
  • COVID-19の中での価格ダイナミクス
  • 需要-供給スペクトラム
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的な取り組み
  • まとめ

第7章 製品タイプ別

  • ELISA HEV IgMテストキット
  • ELISA HEV IgGテストキット
  • RT-PCR検査キット
  • その他

第8章 検査タイプ別

  • 血液
  • 便
  • その他

第9章 エンドユーザー別

  • 病院
  • 診断ラボ
  • ポイントオブケア
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第11章 競合情勢

  • 主な展開と戦略
  • 企業シェア分析
  • 製品ベンチマーク
  • 注目の主要企業リスト

第12章 企業プロファイル

  • Diagnostic Automation/Cortez Diagnostics, Inc.
    • 企業概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • EUROIMMUN Medizinische Labordiagnostika AG
  • Dia.Pro-Diagnostic Bioprobes s.r.l
  • Biokit S.A.
  • altona Diagnostics GmbH
  • ORGENTEC Diagnostika
  • Fortress Diagnostics
  • Mikrogen GmBH
  • Primerdesign Ltd
  • F. Hoffmann-La Roche Ltd.

第13章 E型肝炎診断検査の世界市場-DataM

目次
Product Code: DM5780

Market Overview

Hepatitis E Diagnostic Tests Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 4.5 % during the forecast period (2022-2029).

The hepatitis E virus causes the enteric liver disease known as hepatitis E. (HEV). It belongs to the group of five known human hepatitis viruses (A, B, C, D, and E). Due to the feces in the water being a source of contamination, it is spread by fecal-oral contact. Hepatitis E cannot currently be diagnosed using an officially recognized test. Doctors rely on testing to identify the antibodies that fight the virus to diagnose hepatitis E correctly. It often relies on finding specific anti-HEV immunoglobulin M (IgM) antibodies to the virus in a person's blood; this is usually sufficient in regions where the disease is prevalent. For field use, rapid testing is available.

Market Dynamics

The development of a Novel Recombinant Protein-based Diagnostic Kit for Hepatitis E is expected to drive market growth.

Biotech Consortium India Limited has developed a technology that is a sensitive test for detecting HEV infection compared to other commercial assay kits. The technology is based on using Swine HEV's Open Reading Frame-2 for the development of Hepatitis E testing kits. The gene sequence underwent a 2-percent alteration in the current technology, leading to increased HEV protein production for better protein identification in the patient's sera sample and increased diagnostic kit effectiveness. This is a technology platform that can be used to create vaccines. Moreover, the technology benefits by detecting genotypes 1& 4 and has higher sensitivity. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint:

Lack of awareness among the population, high cost of diagnostic procedures and inadequate reimbursement regulations are some factors the market is expected to hamper in the forecast period.

Global Hepatitis E Diagnostic Tests Market - Industry Analysis

The hepatitis E diagnostic tests market provides in-depth analysis of the market based on various industry factors such as porter's five forces, reimbursement scenario, pricing analysis, supply chain etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted healthcare systems and the market. The COVID-19 pandemic has disrupted healthcare systems, making it more difficult to provide basic clinical care, hepatitis E virus antibody testing, and treatment. As a result, increased morbidity and mortality rates may result from those who had undiagnosed hepatitis E virus during the pandemic subsequently being found to have the disease in more advanced stages. Moreover, as part of the original COVID-19 pandemic mitigation initiatives, the CDC published guidelines on deferring routine clinical visits and delaying non-essential operations. By this advice, patients should avoid making unnecessary in-person visits and communicate with their healthcare practitioner via telemedicine, patient portals, phone, and email.

Additionally, the pandemic interrupts the supply chain and process. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of the economic activities.

Segment Analysis

ELISA HEV IgM Test kits segment is expected to hold the largest market share in hepatitis E diagnostic tests market

The ELISA HEV IgM test kits segment is expected to dominate in 2021. HEV infection typically takes 2 to 6 weeks to develop. HEV RNA and anti-HEV IgM antibodies can be found at the time of diagnosis, followed by anti-HEV IgG antibodies. Positive anti-HEV IgM antibody results in serum can significantly indicate acute HEV infection. Anti-HEV IgM antibodies typically only remain positive for a few months (about 3-4 mo), although occasionally they do. The precise length of this response is still unknown. However, the anti-HEV IgG antibody is comparatively long-lasting.

Additionally, the avidity of the anti-HEV IgG antibody increases over time. Therefore, the demand for the ELISA HEV IgM Test kits increases. It is because it is a third-generation Enzyme ImmunoAssay (ELISA) for qualitatively determining IgG antibodies to Hepatitis E Virus in human plasma and sera. The kit is intended for the follow-up of HEV-infected patients. Thus, from the above statements, the market segment is expected to hold the largest market share in the forecast period.

Geographical Analysis

Asia Pacific region holds the largest market share in the global hepatitis E diagnostic tests market

In 2021, Asia Pacific accounted for the highest revenue share. The increasing prevalence of Hepatitis E cases, rising geriatric population, increasing consumption of pork, rise in adoption of Hepatitis E tests and product launches by the market players in the region are some factors the market is expected to boost in the forecast period. For instance, according to the National Center for Biotechnology Information, nearly 60% of blood donors in India have circulating anti-HEV IgG antibodies, indicating prior exposure to the virus, indicating that HEV infection and illness are extremely endemic country. The seroprevalence rates differ by age, with older people having greater rates. 5 Hepatitis E causes almost half of all instances of acute hepatitis and a comparable percentage of cases of acute liver failure (ALF).

Moreover, the middle and northern regions of India are where most of the country's pigs are found. Assam had more than two million people in 2019. Since swine is thought to be the main carrier of HEV, the largest pork intake suggests that the disease is spread through zoonotic agents. Thus, it has increased the demand for hepatitis E diagnostic tests, due to which the Asia Pacific is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the hepatitis E diagnostic tests market are Diagnostic Automation / Cortez Diagnostics, Inc., EUROIMMUN Medizinische Labordiagnostika AG, Dia.Pro - Diagnostic Bioprobes s.r.l , Biokit S.A., altona Diagnostics GmbH, ORGENTEC Diagnostika, Fortress Diagnostics, Mikrogen GmBH, Primerdesign Ltd, F. Hoffmann-La Roche Ltd.

altona Diagnostics GmbH:

Overview:

altona Diagnostics is a privately held medical diagnostic company headquartered in Hamburg-Altona, Germany. The business creates and produces in-vitro diagnostic tests for the DNA-based identification of pathogens like viruses, bacteria, and parasites. The company has over 20 years of experience in the molecular diagnostics industry and has received the ISO 13485 certification. Through subsidiaries and more than 40 distribution partners, altona Diagnostics provides its certified products to private and clinical laboratories worldwide. Additionally, altona Diagnostics' diagnostic tests are offered as ready-to-use kits based on real-time PCR technology. Over 50 CE-marked kits compatible with open real-time PCR platforms are available in the company's product line. Further, altona Diagnostics provides an automated workflow system that includes apparatus, specialized software, and chemistry for nucleic acid extraction.

Product Portfolio:

RealStar HEV RT-PCR Kit 2.0: The RealStar HEV RT-PCR Kit 2.0 is an in vitro diagnostic test, based on real-time PCR technology, for detecting and quantifying hepatitis E virus (HEV) specific RNA.

The global hepatitis E diagnostic tests market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. The development of a Novel Recombinant Protein-based Diagnostic Kit for Hepatitis E is expected to drive market growth.
    • 4.1.2. Restraints:
      • 4.1.2.1. High cost of diagnostic procedures and inadequate reimbursement regulations are expected to hamper the market growth.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Supply Chain Analysis
  • 5.2. Pricing Analysis
  • 5.3. Unmet Needs

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type Segment
  • 7.2. ELISA HEV IgM Test kits*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. ELISA HEV IgG Test Kits
  • 7.4. RT-PCR Test Kits
  • 7.5. Others

8. By Test Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 8.1.2. Market Attractiveness Index, By Test Type Segment
  • 8.2. Blood*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Stool
  • 8.4. Others

9. By End user

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 9.1.2. Market Attractiveness Index, By End user Segment
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Diagnostic Laboratories
  • 9.4. Point of Care
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End user

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking
  • 11.4. List of Key Companies to Watch

12. Company Profiles

  • 12.1. Diagnostic Automation / Cortez Diagnostics, Inc.*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. EUROIMMUN Medizinische Labordiagnostika AG
  • 12.3. Dia.Pro - Diagnostic Bioprobes s.r.l
  • 12.4. Biokit S.A.
  • 12.5. altona Diagnostics GmbH
  • 12.6. ORGENTEC Diagnostika
  • 12.7. Fortress Diagnostics
  • 12.8. Mikrogen GmBH
  • 12.9. Primerdesign Ltd
  • 12.10. F. Hoffmann-La Roche Ltd.

LIST NOT EXHAUSTIVE

13. Global Hepatitis E Diagnostic Tests Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Applications
  • 13.3. Contact Us